- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ankylosing spondylitis
- Meeting Date: July 2021
- Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 842KB)
- Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 60KB)
Secukinumab – July 2021
Secukinumab: Injection 150 mg in 1 mL pre-filled pen; Cosentyx®
Last updated
12 November 2021